Effect of elexacaftor-tezacaftor-ivacaftor on lipid parameters in adults with cystic fibrosis: A single centre preliminary report-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Effect of elexacaftor-tezacaftor-ivacaftor on lipid parameters in adults with cystic fibrosis: A single centre preliminary report

Published:2024-11 Issue: Volume:86 Page:101102
ISSN:2590-0412
Container-title:Respiratory Medicine and Research
language:en
Short-container-title:Respiratory Medicine and Research

Author:

Docherty Ronan^ORCID,Folganan Jennifer,Dempsey Owen

Publisher

Elsevier BV

Reference14 articles.

1. Elexacaftor–tezacaftor–ivacaftor for cystic fibrosis with a single Phe508del allele;Middleton;N Engl J Med,2019

2. Efficacy and safety of the elexacaftor plus tezacaftor plus ivacaftor combination regimen in people with cystic fibrosis homozygous for the F508del mutation: a double-blind, randomised, phase 3 trial;Heijerman;The Lancet,2019

3. A review of trikafta: triple cystic fibrosis transmembrane conductance regulator (CFTR) modulator therapy;Zaher;Cureus,2021

4. Effect of elexacaftor-tezacaftor-ivacaftor on body weight and metabolic parameters in adults with cystic fibrosis;Petersen;J Cyst Fibros,2021

5. Elevated serum cholesterol is a risk factor for both coronary heart disease and thromboembolic stroke in Hawaiian Japanese men. Implications of shared risk;Benfante;Stroke,1994

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP